Skip to main content
FinSpry Logo
FinSpry
NEO logo
NEO
(NASDAQ)
NeoGenomics, Inc.
$8.00-- (--)
Loading... - Market loading
OverviewFinancialsForecastStatisticsDividendsHistoricalProfile

NeoGenomics (NEO) Stock Price & Financial Analysis

NeoGenomics Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$7.24 - $8.01
52-Week High$13.74
52-Week Low$4.72
Open$7.68
Volume1.79M
Average Volume (3M)1.79M
Market Cap204.96M
Shares Outstanding25.62M
Price to Sales (P/S)0.27
Price to Book (P/B)0.24
EV/EBITDA-13.44
Revenue (TTM)727.33M
Net Income (TTM)-108.03M
Free Cash Flow (TTM)-21.78M
EPS (TTM)$-4.20
Profit Margin-14.85%
Operating Margin-11.89%
Return on Equity (ROE)-12.91%
Debt to Equity0.56
50-Day MA$9.95
200-Day MA$9.30
52-Week Change-17.11%
Annual Dividend$0.00
Dividend Yield0.00%
Last Dividend Ex-DateDec 17, 2020

Frequently Asked Questions About NeoGenomics

What is the current stock price for NEO?

As of the latest trading session, NEO stock trades at $8.00. The 52-week range is $4.72–$13.74, with a day range of $7.24–$8.01.

What is the P/E ratio for NEO?

The P/E ratio (Price-to-Earnings) for NEO is shown in the Key Statistics section. This valuation metric helps compare NeoGenomics, Inc. to industry peers.

Does NEO pay dividends?

NeoGenomics does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.

What do analysts recommend for NEO?

Based on 4 analysts, the consensus for NEO is Buy. The average 12-month price target is $NaN, representing a NaN% downside from the current price.

What is the market cap of NEO?

NeoGenomics's market capitalization is $205.0M, classifying it as a micro-cap company. NeoGenomics operates in the Healthcare sector within the Diagnostics & Research industry.